← Leaderboards
Megan O Bensignor
University Of Minnesota
$1,004,600
Attributed
$1,004,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $202.1K · FY2021–25$250K$187.5K$125K$62.5K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,004,600 · 1
By mechanism
K23$1,004,600 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Aaron S Kelly$16,229,552
- Claudia K Fox$4,104,259
- Jerica M Berge$18,548,585
- Bruce R. Blazar$144,460,093
- Eric Morris Bomberg$1,006,851
Others in their field
Other Emerging Leaders on “Desire For Food”
- Angelo A. Cardoso · Beckman Research Institute/City Of Hope$10,820,438
- Richard Joseph Johnson · Colorado Research Partners, Llc$6,102,731
- Yuki Oka · California Institute Of Technology$4,761,250
- Claudia K Fox · University Of Minnesota$4,104,259
- Troy S Sprecker · Wisconsin Dept/Agri/Trade/Consum/ Prot$3,477,287
- Gina L.c. Yosten · Saint Louis University$2,744,781
Research focus
Desire For Food20 Year OldAdolescentDesignAgedAdolescent ObesityAgonistAdultAtherosclerosisAdult ObesityBody FatBody Mass IndexBody Weight DecreasedCareerCell PhysiologyCellsChildhoodClinical Practice GuidelineClinical TrialsClinical Trials DesignComorbidityBeta CellDependenceDeterioration
Grant awards (5)
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes$200,620
K23 · FY2025 · DK · contact PI
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes$200,620
K23 · FY2024 · DK · contact PI
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes$200,620
K23 · FY2023 · DK · contact PI
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes$200,620
K23 · FY2022 · DK · contact PI
Anti-obesity pharmacotherapy to decrease BMI and improve insulin sensitivity in adolescents with obesity and type 2 diabetes$202,120
K23 · FY2021 · DK · contact PI